Mary Kay Inc. has announced it will dedicate part of its global supply chain and manufacturing capabilities in order to produce hand sanitizer amid the COVID-19 pandemic. The first products off the line will be for donation to those on the front lines of fighting the coronavirus outbreak.
Related: 5 Cosmetic Giants Combating COVID-19
The Centers for Disease Control and Prevention (CDC) recommends the use of alcohol-based hand sanitizers to prevent infections. But because of consumer demand, there’s been a great shortage in CDC-recommended hand sanitizer in homes and health care settings.
Over the past week Mary Kay has been working to move into production by procuring raw materials, determining packaging availability on hand, preparing the manufacturing production lines and ensuring shipping.
The first batch of hand sanitizer products will be donated to the Baylor Scott & White Dallas Foundation. Baylor Scott & White is the largest not-for-profit health care system in Texas and one of the largest in the United States. It includes 52 hospitals, more than 800 patient care sites, 7,500 active physicians and over 47,000 staff.
“Though we are facing extraordinary challenges during the COVID-19 global pandemic, the world is finding ways to adjust—with little or no warning,” David Holl, chairman and CEO at Mary Kay Inc., said. “Producing hand sanitizer to combat this crisis is how we can support those on the front lines.”
“During this unprecedented time, our dedicated medical team continues to faithfully serve those who need us most,” Kristi Sherrill Hoyl, chief policy and community officer at Baylor Scott & White Health, said. “We are humbled by Mary Kay’s generosity and innovation in producing a critical asset for our patients and staff. It’s inspiring to work with organizations within our community with a strong desire to make a difference.”
